Significance statement (120 words) 44 45 Many FIC proteins regulate target proteins by addition of AMP, a reaction coined 46
FIC proteins regulate molecular processes in bacteria and animals by carrying out various 23 post-translational modifications (PTM) of proteins by phosphate-containing compounds. The 24 most frequent FIC-catalyzed PTM is the addition of AMP using ATP as a cofactor, a reaction 25 coined AMPylation. In a large subgroup of FIC proteins, AMPylation is inhibited by a 26 structurally conserved glutamate, but a diffusible signal able to relieve autoinhibition has not 27 been identified. Here, we addressed this issue by studying two members of this subgroup, a 28 single-domain FIC protein from the bacterial pathogen Enterococcus faecalis (EfFIC) and 29 human HYPE/FicD, which is involved in the unfolded protein response in the endoplasmic 30 reticulum. By combining structural and biochemical analysis, we find that EfFIC catalyzes 31 both AMPylation and deAMPylation, and that both enzymatic activities are borne by the same 32 active site. Remarkably, the conserved glutamate implements a multi-position metal switch, 33 whereby different metals support or inhibit each of these reactions. As a result, the balance 34 between the AMPylation and deAMPylation activities of EfFIC is controlled by the 35 Mg 2+ /Ca 2+ ratio, with Ca 2+ favoring deAMPylation. Furthermore, we show that 36 deAMPylation of the endoplasmic reticulum BIP chaperone by human FicD/HYPE is 37 dependent on the Mg 2+ /Ca 2+ ratio, with high Ca 2+ concentration impairing deAMPylation. Our 38 findings suggest that the conserved glutamate is a signature of AMPylation/deAMPylation 39 bifunctionnality in FIC proteins. They also identify for the first time a diffusible signal that 40 can rapidly modulate these opposing activities, which opens important perspectives for their 41 functions in bacterial stress and human ER homeostasis. 42 glutamate, but a diffusible activation signal has not been identified. Here we discover that the 48 FIC protein from the pathogen Enterococcus faecalis catalyzes both AMPylation and 49 deAMPylation and that its conserved glutamate implements a multi-position metal switch that 50 controls the balance between these activities. Furthermore, we show that a metal, Ca 2+ , also 51 tunes deAMPylation of the BIP chaperone by the related human FicD/HYPE protein. These 52 findings identify for the first time a diffusable signal that can rapidly tune FIC proteins, with 53 important implications in bacterial stress and in the unfolded protein response in the ER. 54 55 Introduction revealed that ATP binds to the active site of glutamate-containing FIC proteins in a manner 91 where its γ-phosphate is not stabilized by interactions with the active site (7) and the α-and β-92 phosphates are bound in a non-canonical conformation (11), while mutation of the glutamate 93 creates space such that the γ-phosphate can interact with the FIC active site (7) . These 94 observations led to propose that this conserved glutamate implements autoinhibition by 95
impairing the utilization of ATP as a donor for AMP, hence that it must be displaced to allow 96 productive binding of ATP (7) . In N. meningitidis FIC (NmFIC), activation has been proposed 97 to occur upon changes in toxin concentration (19) . In this scheme, NmFIC is in an inactive 98 tetrameric state at high concentration, which is further stabilized by ATP, while its dilution 99 promotes its conversion to a monomeric state, leading to activation by displacement of the 100 inhibitory glutamate followed by auto-AMPylations that reinforce its activation (19) . 101 102 However, diffusible signals able to control autoinhibition in glutamate-bearing AMPylating 103 FIC proteins have not been identified. In addition, in a recent new twist, metazoan 104 HYPE/FicD was shown to carry out deAMPylation as its primary enzymatic activity, and the 105 conserved glutamate was found to be critical for this reaction (20). These intringuing 106 observations challenge the model in which autoinhibition by the conserved glutamate would 107 be the sole mode of regulation of glutamate-containing AMPylating FIC proteins. In this 108 study, we addressed this question by combining structural and biochemical analysis of a 109 single-domain FIC protein from Enterococcus faecalis (EfFIC). Enteroccoci are commensals 110 of the gastrointestinal tract that become pathogenic outside of the gut and cause difficult-to-111 treat infections in the hospital due to acquisition and transmission of antibiotic resistance (21 , 112
Results. 122 123
Structural basis for EfFIC AMPylation activity. 124
125
Enterococcus faecalis FIC belongs to class III FIC proteins, which are comprised of a single 126 FIC domain and carry an autoinhibitory glutamate in their C-terminal α-helix. We determined 127 crystal structures of unbound, phosphate-bound, AMP-bound and ATPγS-bound wild-type 128
EfFIC (EfFIC WT ) and of unbound and sulfate-bound EfFIC carrying a mutation of the 129 catalytic histidine into an alanine (EfFIC H111A ) ( Table 1 and Table S1 ). These structures 130 were obtained in different space groups, yielding 32 independent copies of the EfFIC 131 monomer in various environments in the crystal. All EfFIC monomers resemble closely to 132 each other and to structures of other class III FIC proteins ( Figure 1A) . Notably, the C-133
terminal α-helix that bears the inhibitory glutamate shows no tendency for structural 134 flexibility, even in subunits that are free of intersubunit contacts in the crystal. The glutamate 135 has the same conformation as in other glutamate-bearing FIC protein structures ( Figure 1B ) 136 and is stabilized by intramolecular interactions and interactions with the nucleotide cofactor, 137 when present ( Figure 1C) . Two crystal structures were obtained in co-crystallization with a 138 non-hydrolyzable ATP analog (ATPγS), for which well-defined electron density was 139 observed for the ADP moiety ( Figure S1A) . The positions of the α and β phosphates of 140 ATPγS in these structures depart markedly from those seen in ATP bound unproductively to 141 wild type NmFIC, in which only the ADP moiety is visible as in our structures (7), or bound 142 non-canonically to CdFIC (11) ( Figure 1D) . In contrast, they superpose well to cofactors 143 bound in a position competent for PTM transfer (7, 8 ) ( Figure 1E ). This observation 144 prompted us to assess whether EfFIC is competent for AMPylation, using autoAMPylation 145 which is a convenient proxy when the physiological target is not known (reviewed in (18)). 146
Using [α-32 P]-ATP and autoradiography to measure the formation of AMPylated EfFIC 147 (denoted AMP* EfFIC WT ), we observe that EfFIC WT has conspicuous autoAMPylation activity 148 in the presence of Mg 2+ (Figure 1F) . AMPylation is increased in EfFIC E190G , in which the 149 inhibitory glutamate is mutated into glycine, indicating that this activity is not optimal in 150 EfFIC WT (Figure 1F ). We conclude from these experiments that wild-type EfFIC has 151 canonical features of an AMPylating FIC enzyme, and that the inhibitory glutamate mitigates 152 this activity. 153
156
To gain further insight into the activity of EfFIC, we solved the crystal structure of EfFIC 157 bound to AMP (EfFIC WT -AMP) ( Table 1 and Table S1 ). AMP superposes exactly to the 158 AMP moiety of AMPylated CDC42 in complex with the FIC2 domain of the IbpA toxin (5) 159 (Figure 2A) . Electron-rich density was observed next to AMP in the active site, 160
corresponding to a calcium ion present in the crystallization solution to the exclusion of all 161 other metal ions (Figure S1B) . Ca 2+ has 6 coordinations with distances in the expected 2.1-162 2.9 Å range, arranged with heptahedral geometry in which one ligand, which would be 163 (Figure 2E , control panel), indicating that the 183 deAMPylation reaction occurs in trans. We used this deAMPylation setup to identify residues 184 critical for de-AMPylation (Figure 2E , mutant panels). Mutation of the catalytic histidine 185 (H111A) and of the metal-binding acidic residue in the FIC motif (E115A) impaired 186 deAMPylation of AMP-FAM EfFIC E190G . EfFIC E190G , which carries the mutation of the inhibitory 187 glutamate, was also unable to promote deAMPylation, consistent with the absence of bifunctional enzyme, that AMPylation and deAMPylation are borne by the same active site, 190 and that the inhibitory glutamate is involved in the deAMPylation reaction. differentially, we determined the crystal structure of EfFIC WT -ATPγS-Ca 2+ . Ca 2+ is 210 heptacoordinated to the α-and β-phosphates of ATPγS, of which only the ADP moiety is 211 visible, to the inhibitory glutamate and to 4 water molecules ( Figure 3D) . In contrast, it does 212 not form a direct or water-mediated interaction with the acidic residue in the FIC motif, which 213 binds to Mg 2+ in AMPylation competent structures {Engel, 2012 #33}. Remarkably, the 214 position of Ca 2+ is shifted with respect to that of Mg 2+ , in a manner that Mg 2+ and Ca 2+ may 215 compete with each other in AMPylation (Figure 3E) . We tested this hypothesis by measuring 216 the apparent AMPylation efficiency of EfFIC WT at different Mg 2+ /Ca 2+ ratio. As shown in 217 Figure 3F , AMPylation is prominent when Mg 2+ exceeds Ca 2+ , while Ca 2+ in excess over 218 Mg 2+ favors deAMPylation. We conclude from these experiments that AMPylation and 219 deAMPylation efficiencies in EfFIC are regulated by a metal switch and that this regulatory 220 mechanism is implemented by differential usage of the inhibitory glutamate and the acidic 221 residue in the FIC motif for metal binding. 222
DeAMPYlation of the BIP chaperone by human FicD/HYPE is tuned by Ca 2+ 224 225
DeAMPylation has been recently identified as the primary activity of human HYPE/FicD 226 (20), which features a glutamate structurally equivalent to the inhibitory glutamate in EfFIC 227 (see Figure 1B , (10)) that is critical for deAMPylation of BIP (20). We analyzed whether, as 228 observed in EfFIC, Mg 2+ and Ca 2+ metals could also affect FicD/HYPE activity, using 229 fluorescent ATP-FAM to monitor BIP AMPylation levels. No measurable AMPylation of BIP 230 by HYPE WT was observed, neither with Mg 2+ nor Ca 2+ , although HYPE WT itself showed some 231 level of autoAMPylation with both metals (Figure 4A) . Alternatively, we used HYPE E234G , 232 which carries the mutation of the conserved glutamate, to produce AMPylated BIP. 233
Remarkably, while purified AMP-FAM BIP was efficiently deAMPylated by HYPE WT in the 234 presence of Mg 2+ , no deAMPylation was measured in the presence of Ca 2+ (Figure 4B) . To 235 determine whether FicD/HYPE does not bind Ca 2+ or is unable to use it for deAMPylation, 236
we carried out a Mg 2+ /Ca 2+ competition experiment in which HYPE WT and purified AMP-237 FAM BIP were incubated at increasing Ca 2+ concentration and a fixed Mg 2+ concentration. As 238 shown in Figure 4C , deAMPylation efficiency decreased as the Ca 2+ /Mg 2+ ratio increased, 239
suggesting that Ca 2+ inhibits deAMPylation by competing with Mg 2+ . We conclude from 240 these experiments that Ca 2+ binds to FicD/HYPE in a catalytically incompetent manner, In this study, we sought after a diffusible signal able to regulate the large group of glutamate-247
bearing AMPylating FIC proteins. Combining structural and biochemical observations, we 248 first show that bacterial EfFIC is a bifunctional enzyme that encodes AMPylating and 249 deAMPylating activities and that both reactions use the same active site. Next, we discover 250 that the balance between these opposing activities is controlled by a metal switch, in which 251 each reaction is differentially supported and inhibited by Mg 2+ and Ca 2+ in a manner that the 252 Mg 2+ /Ca 2+ ratio determines the net AMPylation level. Furthermore, we identify the inhibitory 253 glutamate and the acidic residue in the FIC motif as residues essential for the metal switch. 254
Finally, we show that deAMPylation of the endoplasmic reticulum BIP chaperone by human In addition, both the acidic residue of the FIC motif and the conserved glutamate contribute to 276 binding a catalytic metal, which stabilizes the phosphate of the AMP moiety at the transition 277 state. A remarkable feature in the above bifunctional mechanism is that both reactions can be 278 adversely regulated by a second metal that competes with the catalytic metal. In EfFIC, we 279 observed that Ca 2+ binds to ATP in a shifted position with respect to the canonical 280 Recently, FicD/HYPE has been demonstrated to stimulate the activity of the BIP chaperone in 312 response to an increase in the unfolded protein load (13-15, 23), and this relies on its 313 deAMPylation of BIP (20). Ca 2+ is a fast and efficient messenger that is critical for ER 314 homeostasis, where its depletion swiftly alters protein folding processes and activates the 315 unfolded protein response (reviewed in (26 , 27) ). It is thus tempting to speculate that 316 inhibition of FicD/HYPE deAMPylation at high Ca 2+ , which we observe in vitro, reflects its 317 inhibition under ER homeostasis, where Ca 2+ concentration is high and BIP activity is not 318
required. Conversely, depletion of Ca 2+ induces ER stress and triggers the UPR. Depletion of 319
Ca 2+ may thus release inhibition of FicD/HYPE, leading to efficient deAMPylation of BIP 320 and up-regulation of its activity, which is a key feature of the UPR. In this model, 321
FicD/HYPE functions as an integrator between Ca 2+ homeostasis in the ER and the BIP-322 mediated unfolded protein response.
In conclusion, we have identified a diffusable and rapidly tunable signal that can modulate the 325 intrinsic enzymatic activity of glutamate-bearing FIC proteins and tip the balance between 326
AMPylation and deAMPylation reactions, with major implications in bacterial and human 327 physiology and a potential impact in infections and ER diseases. Future studies are now 328 needed to investigate how the metal switch of glutamate-bearing FIC protein activities is 329 exploited in bacterial stress, and, in the case of animal FiD/HYPE, its role in the unfolded 330 protein response and its crosstalks with Ca 2+ -controled processes in the ER. 331 Softwares used in this project were curated by SBGrid (32). Crystallization conditions, data 472 collection statistics and refinement statistics are given in Table S1 . All structures have been 473 deposited with the Protein Data Bank (PDB codes in Table S1 ). International PhD program. We are grateful to the scientific teams at the PX1 and PX2 519 beamlines at the SOLEIL synchrotron (Gif-sur-Yvette, France) and from the ID29, ID30-A3 520 and ID30B beamlines at the European Synchrotron Research Facility (ESRF, Grenoble, 521
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